Edgar Gonzalez-Kozlova, PhD, Emphasizes the Potential for Circulating Soluble Proteins to Predict Response to Immunotherapy in Lung Cancer
Edgar Gonzalez-Kozlova, PhD, discusses his study suggesting that blood circulating soluble proteins could be a promising predictor of outcomes for patients with squamous cell lung cancer.